MONTREAL, QUEBEC -- (MARKET WIRE) -- 06/13/2006 -- Ambrilia Biopharma Inc. (TSX: AMB), a biopharmaceutical company developing innovative therapeutics in the fields of cancer and infectious diseases, announced today that it will hold its Annual General Meeting of Shareholders on Tuesday, June 20, 2006, at 10:30 a.m. (E.T.) at Centre Mont-Royal (Salon International I-II), 2200 Mansfield Street, Montreal, Quebec.
